Stock listing
NASDAQ:VTGN Vistagen Therapeutics, Inc. Stock
Home listing (NASDAQ) of Vistagen Therapeutics, Inc.
Follow Vistagen Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VTGN
$0.203 USD +0.003 (+1.5%)
Close on Oct 19, 2026
- Day range
- $0.193 – $0.210 USDOct 19, 2026
- Volume
- 1.04M sharesOct 19, 2026
- Market cap
- $9.01M USDAt the close on Oct 19, 2026 · price × 44.38M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VTGN · Home | $0.203 USD | +0.003 (+1.5%) | 1,037,937 | $0.206 | $0.210 | $0.193 | $0.200 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:VTGN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.203 | +0.003 | +1.5% | $0.206 | $0.210 | $0.193 | 1,037,937 | |
| $0.200 | -0.013 | -6.1% | $0.209 | $0.219 | $0.198 | 557,972 | |
| $0.213 | +0.006 | +3.1% | $0.205 | $0.216 | $0.200 | 873,875 | |
| $0.207 | -0.008 | -3.8% | $0.206 | $0.210 | $0.200 | 988,417 | |
| $0.215 | -0.012 | -5.2% | $0.223 | $0.225 | $0.212 | 1,028,046 | |
| $0.227 | -0.010 | -4.0% | $0.236 | $0.236 | $0.221 | 739,900 | |
| $0.236 | -0.010 | -4.1% | $0.240 | $0.245 | $0.236 | 404,864 | |
| $0.246 | -0.004 | -1.5% | $0.246 | $0.250 | $0.237 | 959,298 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.260 | $0.240 | 774,600 | |
| $0.250 | -0.010 | -3.8% | $0.270 | $0.270 | $0.250 | 1,595,700 | |
| $0.260 | -0.020 | -7.1% | $0.280 | $0.280 | $0.260 | 1,916,600 | |
| $0.280 | 0.000 | 0.0% | $0.280 | $0.300 | $0.280 | 1,250,500 | |
| $0.280 | -0.030 | -9.7% | $0.310 | $0.310 | $0.280 | 2,031,000 | |
| $0.310 | +0.010 | +3.3% | $0.290 | $0.320 | $0.280 | 2,427,300 | |
| $0.300 | 0.000 | 0.0% | $0.290 | $0.300 | $0.280 | 2,025,600 | |
| $0.300 | +0.030 | +11.1% | $0.270 | $0.320 | $0.270 | 6,030,100 | |
| $0.270 | -0.030 | -10.0% | $0.280 | $0.300 | $0.260 | 5,572,000 | |
| $0.300 | -0.070 | -18.9% | $0.350 | $0.360 | $0.270 | 20,471,700 | |
| $0.370 | +0.120 | +48.0% | $0.390 | $0.550 | $0.340 | 574,960,000 | |
| $0.250 | +0.020 | +8.7% | $0.250 | $0.270 | $0.240 | 5,999,800 | |
| $0.230 | -0.010 | -4.2% | $0.240 | $0.240 | $0.230 | 332,100 | |
| $0.240 | +0.010 | +4.3% | $0.230 | $0.250 | $0.230 | 718,200 | |
| $0.230 | 0.000 | 0.0% | $0.240 | $0.240 | $0.230 | 362,500 | |
| $0.230 | -0.010 | -4.2% | $0.240 | $0.240 | $0.230 | 548,700 | |
| $0.240 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 194,400 | |
| $0.240 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 238,800 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.230 | 310,000 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.230 | 339,900 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.230 | 801,600 | |
| $0.240 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 319,300 | |
| $0.240 | -0.010 | -4.0% | $0.250 | $0.260 | $0.240 | 347,200 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 250,600 | |
| $0.250 | +0.010 | +4.2% | $0.240 | $0.250 | $0.240 | 197,900 | |
| $0.240 | -0.020 | -7.7% | $0.250 | $0.250 | $0.240 | 596,000 | |
| $0.260 | +0.010 | +4.0% | $0.260 | $0.260 | $0.240 | 466,500 | |
| $0.250 | -0.010 | -3.8% | $0.260 | $0.260 | $0.250 | 449,200 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.270 | $0.250 | 339,100 | |
| $0.260 | +0.010 | +4.0% | $0.250 | $0.270 | $0.240 | 562,400 | |
| $0.250 | +0.010 | +4.2% | $0.250 | $0.250 | $0.240 | 712,400 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 477,000 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 990,800 | |
| $0.240 | 0.000 | 0.0% | $0.250 | $0.250 | $0.230 | 705,700 | |
| $0.240 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 404,900 | |
| $0.240 | -0.020 | -7.7% | $0.250 | $0.270 | $0.240 | 2,298,900 | |
| $0.260 | -0.010 | -3.7% | $0.270 | $0.270 | $0.260 | 1,035,000 | |
| $0.270 | 0.000 | 0.0% | $0.270 | $0.270 | $0.260 | 913,200 | |
| $0.270 | +0.010 | +3.8% | $0.260 | $0.270 | $0.260 | 304,000 | |
| $0.260 | -0.010 | -3.7% | $0.270 | $0.270 | $0.260 | 759,100 | |
| $0.270 | +0.010 | +3.8% | $0.270 | $0.280 | $0.250 | 1,222,300 | |
| $0.260 | -0.030 | -10.3% | $0.290 | $0.300 | $0.260 | 2,386,300 | |
| $0.290 | +0.010 | +3.6% | $0.290 | $0.310 | $0.280 | 2,555,900 | |
| $0.280 | -0.020 | -6.7% | $0.300 | $0.310 | $0.280 | 3,573,700 | |
| $0.300 | 0.000 | 0.0% | $0.270 | $0.300 | $0.270 | 5,543,800 | |
| $0.300 | +0.050 | +20.0% | $0.260 | $0.320 | $0.260 | 117,914,600 | |
| $0.250 | +0.010 | +4.2% | $0.250 | $0.250 | $0.240 | 895,700 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.250 | $0.240 | 794,200 | |
| $0.240 | 0.000 | 0.0% | $0.250 | $0.250 | $0.240 | 975,700 | |
| $0.240 | +0.010 | +4.3% | $0.230 | $0.250 | $0.230 | 1,082,600 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.240 | $0.220 | 1,602,500 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.230 | $0.220 | 506,200 | |
| $0.230 | 0.000 | 0.0% | $0.220 | $0.230 | $0.220 | 1,150,600 | |
| $0.230 | 0.000 | 0.0% | $0.240 | $0.240 | $0.220 | 1,241,100 | |
| $0.230 | -0.010 | -4.2% | $0.240 | $0.240 | $0.230 | 238,300 | |
| $0.240 | +0.010 | +4.3% | $0.230 | $0.240 | $0.230 | 555,500 | |
| $0.230 | 0.000 | 0.0% | $0.230 | $0.230 | $0.230 | 540,700 |
- Ticker
- NASDAQ:VTGN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 20, 2026
Vistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs
Latest earnings call · Feb 12, 2026
Vistagen Therapeutics (NASDAQ:VTGN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 49 slides
Calls
Replays
Vistagen Therapeutics (NASDAQ:VTGN) Q3 2026 Earnings Call
Thu, Feb 12, 2026 · 5:00 PM ET
Watch TranscriptVistagen Therapeutics (NASDAQ:VTGN) Q2 2026 Earnings Call
Thu, Nov 13, 2025 · 5:00 PM ET
Watch TranscriptVistagen Therapeutics (NASDAQ:VTGN) Q1 2026 Earnings Call
Thu, Aug 07, 2025 · 5:00 PM ET
Watch Transcript
Latest news
Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder
Sep 24, 2026
Closed $0.30 (-18.9%) on Sep 24, 2026
Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Sep 22, 2026
Closed $0.25 (+8.7%) on Sep 22, 2026
Vistagen to Present at Psych Congress 2026
Sep 10, 2026
Closed $0.24 (0.0%) on Sep 10, 2026
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
Aug 14, 2026
Closed $0.27 (0.0%) on Aug 14, 2026
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
Aug 6, 2026
Closed $0.28 (-6.7%) on Aug 6, 2026
Vistagen Appoints Douglas J. Williamson to its Board of Directors
Jul 31, 2026
Closed $0.24 (0.0%) on Jul 31, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 49 slides · September 2026
Technical Presentation (June 2026)
Technical · 8 slides · Jun 30, 2026
Investor Presentation (March 2026)
Investor deck · 47 slides · Mar 16, 2026
Investor Presentation (January 2026)
Investor deck · 45 slides · Jan 9, 2026
Vistagen Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 149 in all · newest Oct 20, 2026 · oldest 2019
- Calls
- 19 calls with a replay · 19 with a transcript · latest Feb 12, 2026
- Decks
- 33 decks · latest September 2026
Where Vistagen Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VTGN · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VTGN | BOATS | United States | USD |
| BMV:VTGN | BMV | Mexico | MXN |
| BIVA:VTGN | BIVA | Mexico | MXN |
Log in to ask 6ix AI your own questions about Vistagen Therapeutics, Inc.